Effectiveness of Intravenous Cyclophosphamide in a Patient With Anti-amphiphysin Autoimmunity Presenting With Bulbar Palsy and Cerebellar Ataxia: A Case Report.

Anti-amphiphysin antibody is a rare paraneoplastic autoantibody. A case of a 74-year-old man with anti-amphiphysin antibody and multiple symptoms, including bulbar palsy along with cerebellar ataxia, who responded to treatment with intravenous cyclophosphamide is reported. The patient presented with progressive unsteady gait and difficulty in swallowing food and water for three months. On admission, he had severe ataxia, downbeat and horizontal nystagmus, dysarthria, dysphagia, loss of tendon reflexes, and dysuria. Anti-amphiphysin antibodies were detected in the serum, resulting in the diagnosis of non-stiff anti-amphiphysin syndrome. No significant abnormalities were observed in imaging studies of the brain and the whole body. The patient was treated with high-dose intravenous immunoglobulin and steroids, yielding only slight improvement. After two courses of intravenous cyclophosphamide pulse therapy, his neurological symptoms, notably dysphagia and cerebellar ataxia, improved. Follow-up computed tomography and fluorodeoxyglucose-positron emission tomography/computed tomography showed enlarged mediastinal lymph nodes and hypermetabolic uptake of F-18 fluorodeoxyglucose six months after the onset of the neurological symptoms. Histological examination of a lymph node showed metastatic small cell lung cancer. This case highlights the efficacy of cyclophosphamide as second-line immunotherapy for anti-amphiphysin syndrome.

Informations de copyright

Copyright © 2024, Nomoto et al.

Déclaration de conflit d'intérêts

Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.